Skip to main content
Premium Trial:

Request an Annual Quote

OSU Center Lands $11.3M for Thyroid Cancer Risk Studies, Resource Cores

NEW YORK (GenomeWeb News) – Investigators at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have reeled in an $11.3 million grant from the National Cancer Institute to pursue genome-focused thyroid cancer studies and to fund shared core resources.

Specifically, the NCI funding will support a study that launched in 2008 called "Genetic and Signaling Pathways in Epithelial Thyroid Cancer," which has four integrated components.

The main thrust of the study so far has been to identify individuals with heightened genetic risk for thyroid cancer to allow for early diagnosis and prediction of tumor behavior. The investigators plan to use the funding to continue to develop their findings so that they may be translated into clinical practice.

The new studies, headed by OSUCCC – James Professor and Principal Investigator Matthew Ringel, will aim to functionally characterize and identify genes that predispose people for papillary thyroid carcinoma, investigate genetic alterations that initiate follicular thyroid carcinogenesis, and determine the role of p21 activated kinase in thyroid cancer.

The cores that will receive funding include an Integrated Clinical Information and Pathology Sample Repository, a Mouse Imaging and Pathology core, and a Biostatistics and Data Integration resource.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.